M&A Deal Summary

Millennium Pharmaceuticals Acquires LeukoSite

On December 22, 1999, Millennium Pharmaceuticals acquired life science company LeukoSite from Perseus

Acquisition Highlights
  • This is Millennium Pharmaceuticals’ 1st transaction in the Life Science sector.
  • This is Millennium Pharmaceuticals’ 1st transaction in the United States.
  • This is Millennium Pharmaceuticals’ 1st transaction in Massachusetts.

M&A Deal Summary

Date 1999-12-22
Target LeukoSite
Sector Life Science
Buyer(s) Millennium Pharmaceuticals
Sellers(s) Perseus
Deal Type Add-on Acquisition

Target

LeukoSite

Cambridge, Massachusetts, United States
LeukoSite, Inc. is a biotechnology company developing proprietary monoclonal antibody and small molecule drugs to treat patients with cancer and inflammatory, autoimmune and viral diseases.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Millennium Pharmaceuticals

Cambridge, Massachusetts, United States

Category Company
Founded 1993
Sector Life Science
Employees966
DESCRIPTION

Millennium Pharmaceuticals, Inc. is a biopharmaceutical company. Millennium research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 1
Year: 1999 M&A 1 of 1

Seller(S) 1

SELLER

Perseus

Washington, District of Columbia, United States

Category Merchant Bank
Founded 1995
PE ASSETS 2.0B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Perseus is a private equity firm focused on middle-market buyouts, recapitalizations, and growth equity investments. Perseus looks businesses operating with proven management, strong brands, and 'powerful intellectual property'. Sectors of interest include biotechnology, medical devices, branded consumer products, business services, information technology, communications, and energy/environmental service companies. Perseus was formed in 1995 and maintains offices in Washington DC, New York City, and Munich.


DEAL STATS #
Overall 5 of 31
Sector: Life Science M&A 2 of 5
Type: Add-on Acquisition M&A Deals 4 of 22
State: Massachusetts M&A 1 of 5
Country: United States M&A 5 of 26
Year: 1999 M&A 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
1999-06-01 Sygma S.A.

United States

Sygma S.A. is a photo press agency with an archive of over 30 million photographs and relationships with approximately 6,000 photographers, provided celebrity and news-related photo stories to magazines and other media organizations.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2000-01-01 Fisk Electric Co.

Houston, Texas, United States

Fisk Electric Co. is a commercial and industrial electrical construction markets in Southwest and Southeast locations with abilities to cover other attractive markets nationwide.

Sell -